Hence, this suggests that IL-17A might induce the formation of an IL-17R-EGFR-TRAF4-Act1 complex to further recruit Src, resulting in EGFR activation in EGFR-mutant NSCLC cells, and this possibility should be investigated in the future. Here, TRAF4 is linked to non-small cell lung carcinoma.